Coffee is one of the three most consumed beverages in the world. It is made by first roasting coffee beans, and then grinding and boiling or steeping the roasted beans in water (brewing). The process of roasting and brewing produces a complex mix of bioactive compounds, including methylxanthines (caffeine, theobromine, theophylline), diterpenes, chlorogenic acid, trigonelline, flavonoids, and hydroxycinnamic acid. In the body, these compounds may be metabolized to produce other bioactive compounds. For example, caffeine is primarily (80%) broken down by demethylation to produce paraxanthine. In the post-ingestion period, levels of paraxanthine may be higher than caffeine due to its slower elimination. Hence, while paraxanthine is not found in coffee itself, it has many of the same properties as caffeine and may be a major contributor to its metabolic effects. The impacts of caffeine and paraxanthine on metabolism relate to their impact on adenosine receptors (notably the A2A receptor). It has been known for almost 100 years that intake of coffee stimulates metabolism by between 5% and 20% for at least 3 h. About half of the increase in metabolic rate after drinking coffee is due to caffeine and derivatives, but the source of the other half is unclear. There are large differences in the response to the same amount of coffee in different individuals, which may be related to caffeine clearance rates, effects of other unknown pathways, genetic polymorphism, age, sex, and body composition.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 214 | 214 | 7 |
PDF Downloads | 232 | 232 | 6 |
Acar-Tek N, Aǧagündüz D & & Ayhan B 2018 Effect of green coffee consumption on resting energy expenditure, blood pressure, and body temperature in healthy women: a pilot study. Journal of the American College of Nutrition 37 691–700. (https://doi.org/10.1080/07315724.2018.1461147)
Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K & & Jéquier E 1980 Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. American Journal of Clinical Nutrition 33 989–997. (https://doi.org/10.1093/ajcn/33.5.989)
Acheson KJ, Gremaud G, Meirim I, Montigon F, Krebs Y, Fay LB, Gay LJ, Schneiter P, Schindler C & & Tappy L 2004 Metabolic effects of caffeine in humans: lipid oxidation or futile cycling? American Journal of Clinical Nutrition 79 40–46. (https://doi.org/10.1093/ajcn/79.1.40)
Aguiar LM, Nobre HV Jr, Macêdo DS, Oliveira AA, Freitas RM, Vasconcelos SM, Cunha GM, Sousa FC & & Viana GS 2006 Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats. Pharmacology, Biochemistry, and Behavior 84 415–419. (https://doi.org/10.1016/j.pbb.2006.05.027)
Aldridge A, Parsons WD & & Neims AH 1977 Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. Life Sciences 21 967–974. (https://doi.org/10.1016/0024-3205(7790263-6)
Aldridge A, Bailey J & & Neims AH 1981 The disposition of caffeine during and after pregnancy. Seminars in Perinatology 5 310–314.
Alsene K, Deckert J, Sand P & & de Wit H 2003 Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28 1694–1702. (https://doi.org/10.1038/sj.npp.1300232)
Anh-Dao L-T, Minh-Huy D, Bui-Phuc T, Nhut-Truong N, Tu-Chi T, Thi-Hoa L, Diem-My H-L, Thanh-Nho N & & Cong-Hau N 2024 Determination of caffeine, chlorogenic acid, total phenolic contents, and antioxidant capacities for arabica and robusta coffee from Vietnam. Analytical Letters 1–15. (https://doi.org/10.1080/00032719.2024.2304126)
Anzueto F, Baumann T, Graziosi G, Piccin C & & van der Vossen H 2005 The plant. In Espresso Coffee. The Science of Quality, pp. 21–86. Amsterdam, Netherland: Elsevier. (https://doi.org/10.1016/B978-012370371-2/50003-2)
Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A & & Neims AH 1979 Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. Journal of Pediatrics 94 663–668. (https://doi.org/10.1016/s0022-3476(7980047-5)
Arlt A, Sebens S, Krebs S, Geismann C, Grossmann M, Kruse ML, Schreiber S & & Schäfer H 2013 Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 32 4825–4835. (https://doi.org/10.1038/onc.2012.493)
Arnaud MJ 1993 Components of coffee. In Caffeine, Coffee and Health, Ed. Garattini S. New York, NY, USA: Raven Press.
Arnaud MJ, Thelin-Doerner A, Ravussin E & & Acheson KJ 1980 Study of the demethylation of [1,3,7-Me-13C] caffeine in man using respiratory exchange measurements. Biomedical Mass Spectrometry 7 521–524. (https://doi.org/10.1002/bms.1200071113)
Astrup A, Toubro S, Cannon S, Hein P, Breum L & & Madsen J 1990 Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. American Journal of Clinical Nutrition 51 759–767. (https://doi.org/10.1093/ajcn/51.5.759)
Axelrod J & & Reichenthal J 1953 The fate of caffeine in man and a method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics 107 519–523.
Baeza G, Sarriá B, Bravo L & & Mateos R 2016 Exhaustive qualitative LC-DAD-MS(n) analysis of arabica green coffee beans: cinnamoyl-glycosides and Cinnamoylshikimic acids as new polyphenols in green coffee. Journal of Agricultural and Food Chemistry 64 9663–9674. (https://doi.org/10.1021/acs.jafc.6b04022)
Banks NF, Tomko PM, Colquhoun RJ, Muddle TWD, Emerson SR & & Jenkins NDM 2019 Genetic polymorphisms in ADORA2A and CYP1A2 influence caffeine's effect on postprandial glycaemia. Scientific Reports 9 10532. (https://doi.org/10.1038/s41598-019-46931-0)
Baraldi PG, Tabrizi MA, Gessi S & & Borea PA 2008 Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility. Chemical Reviews 108 238–263. (https://doi.org/10.1021/cr0682195)
Barbosa MSG, Scholz M, Kitzberger CSG & & Benassi MT 2019 Correlation between the composition of green arabica coffee beans and the sensory quality of coffee brews. Food Chemistry 292 275–280. (https://doi.org/10.1016/j.foodchem.2019.04.072)
Barnes PJ 2006 Theophylline for COPD. Thorax 61 742–744. (https://doi.org/10.1136/thx.2006.061002)
Barone JJ & & Roberts HR 1996 Caffeine consumption. Food and Chemical Toxicology 34 119–129. (https://doi.org/10.1016/0278-6915(9500093-3)
Batista L, de Souza SC, Batista CS & & Schwan R 2016 Coffee: types and production, pp. 244–251. Amsterdam, Netherland: Elsevier. (https://doi.org/10.1016/B978-0-12-384947-2.00184-7)
Beavo JA, Rogers NL, Crofford OB, Baird CE, Hardman JG, Sutherland EW & & Newman EV 1971 Effects of phosphodiesterase inhibitors on cyclic AMP levels and on lipolysis. Annals of the New York Academy of Sciences 185 129–136. (https://doi.org/10.1111/j.1749-6632.1971.tb45243.x)
Belitz H-D, Grosch W & & Schieberle P 2009 Coffee, tea, cocoa. In Food Chemistry, pp. 938–970. Berlin, Germany: Springer. (https://doi.org/10.1007/978-3-540-69934-7_22)
Benowitz NL, Jacob P 3rd, Mayan H & & Denaro C 1995 Sympathomimetic effects of paraxanthine and caffeine in humans. Clinical Pharmacology and Therapeutics 58 684–691. (https://doi.org/10.1016/0009-9236(9590025-X)
Blanchard J & & Sawers SJ 1983a The absolute bioavailability of caffeine in man. European Journal of Clinical Pharmacology 24 93–98. (https://doi.org/10.1007/BF00613933)
Blanchard J & & Sawers SJ 1983b Comparative pharmacokinetics of caffeine in young and elderly men. Journal of Pharmacokinetics and Biopharmaceutics 11 109–126. (https://doi.org/10.1007/BF01061844)
Bonati M, Latini R, Galletti F, Young JF, Tognoni G & & Garattini S 1982 Caffeine disposition after oral doses. Clinical Pharmacology and Therapeutics 32 98–106. (https://doi.org/10.1038/clpt.1982.132)
Boswell-Smith V, Cazzola M & & Page CP 2006 Are phosphodiesterase 4 inhibitors just more theophylline? Journal of Allergy and Clinical Immunology 117 1237–1243. (https://doi.org/10.1016/j.jaci.2006.02.045)
Bruckbauer A & & Zemel MB 2014 Synergistic effects of polyphenols and methylxanthines with leucine on AMPK/sirtuin-mediated metabolism in muscle cells and adipocytes. PLoS One 9 e89166. (https://doi.org/10.1371/journal.pone.0089166)
Callahan MM, Robertson RS, Arnaud MJ, Branfman AR, McComish MF & & Yesair DW 1982 Human metabolism of [1-methyl-14C]- and [2–14C]caffeine after oral administration. Drug Metabolism and Disposition: the Biological Fate of Chemicals 10 417–423.
Caporaso N, Whitworth MB, Grebby S & & Fisk ID 2018 Non-destructive analysis of sucrose, caffeine and trigonelline on single green coffee beans by hyperspectral imaging. Food Research International 106 193–203. (https://doi.org/10.1016/j.foodres.2017.12.031)
Carrillo JA & & Benitez J 1996 CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine. British Journal of Clinical Pharmacology 41 605–608. (https://doi.org/10.1046/j.1365-2125.1996.35418.x)
Chauhan PS, Satti NK, Sharma P, Sharma VK, Suri KA & & Bani S 2012 Differential effects of chlorogenic acid on various immunological parameters relevant to rheumatoid arthritis. Phytotherapy Research 26 1156–1165. (https://doi.org/10.1002/ptr.3684)
Chen X, Wang L, Zhi L, Zhou G, Wang H, Zhang X, Hao B, Zhu Y, Cheng Z & & He F 2005 The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population. Clinical Pharmacology and Therapeutics 78 249–259. (https://doi.org/10.1016/j.clpt.2005.05.012)
Cheng WS, Murphy TL, Smith MT, Cooksley WG, Halliday JW & & Powell LW 1990 Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function. Clinical Pharmacology and Therapeutics 47 516–524. (https://doi.org/10.1038/clpt.1990.66)
Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J & & Kamataki T 1999 Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population. Japanese Journal of Cancer Research: Gann 90 899–902. (https://doi.org/10.1111/j.1349-7006.1999.tb00832.x)
Childs E, Hohoff C, Deckert J, Xu K, Badner J & & de Wit H 2008 Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33 2791–2800. (https://doi.org/10.1038/npp.2008.17)
Chvasta TE & & Cooke AR 1971 Emptying and absorption of caffeine from the human stomach. Gastroenterology 61 838–843. (https://doi.org/10.1016/S0016-5085(1933396-7)
Clarke ND, Kirwan NA & & Richardson DL 2019 Coffee ingestion improves 5 km cycling performance in men and women by a similar magnitude. Nutrients 11. (https://doi.org/10.3390/nu11112575)
Clifford MN 2000 Chlorogenic acids and other cinnamates–nature, occurrence, dietary burden, absorption and metabolism. Journal of the Science of Food and Agriculture 80 1033–1043. (https://doi.org/10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T)
Collins LC, Cornelius MF, Vogel RL, Walker JF & & Stamford BA 1994 Effect of caffeine and/or cigarette smoking on resting energy expenditure. International Journal of Obesity and Related Metabolic Disorders 18 551–556.
Cornelis MC 2015 Toward systems epidemiology of coffee and health. Current Opinion in Lipidology 26 20–29. (https://doi.org/10.1097/MOL.0000000000000143)
Cornelis MC, Monda KL, Yu K, Paynter N, Azzato EM, Bennett SN, Berndt SI, Boerwinkle E, Chanock S, Chatterjee N, et al.2011 Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genetics 7 e1002033. (https://doi.org/10.1371/journal.pgen.1002033)
Corrêa CLO, das Merces Penha E, Dos Anjos MR, Pacheco S, Freitas-Silva O, Luna AS & & Gottschalk LMF 2021 Use of asparaginase for acrylamide mitigation in coffee and its influence on the content of caffeine, chlorogenic acid, and caffeic acid. Food Chemistry 338 128045. (https://doi.org/10.1016/j.foodchem.2020.128045)
Czerwensky F, Leucht S & & Steimer W 2015 CYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations. Therapeutic Drug Monitoring 37 152–160. (https://doi.org/10.1097/FTD.0000000000000119)
da Costa BRB, El Haddad LP & & De Martinis BS 2022 Caffeine content of energy drinks marketed in Brazil. Drug Testing and Analysis 14 1660–1664. (https://doi.org/10.1002/dta.3323)
Daglia M, Papetti A, Aceti C, Sordelli B, Gregotti C & & Gazzani G 2008 Isolation of high molecular weight components and contribution to the protective activity of coffee against lipid peroxidation in a rat liver microsome system. Journal of Agricultural and Food Chemistry 56 11653–11660. (https://doi.org/10.1021/jf802018c)
Daly JW, Bruns RF & & Snyder SH 1981 Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. Life Sciences 28 2083–2097. (https://doi.org/10.1016/0024-3205(8190614-7)
Daly JW, Shi D, Nikodijevic O & & Jacobson KA 1994 The role of adenosine receptors in the central action of caffeine. Pharmacopsychoecologia 7 201–213.
Davídek T & & Blank I 2005 Elucidating the secrets of the Maillard reaction cascade–the role of Amadori compounds: highlights of analytical chemistry in Switzerland. Chimia 59 862–862. (https://doi.org/10.2533/000942905777675642)
Davis AP, Tosh J, Ruch N & & Fay MF 2011 Growing coffee: psilanthus (Rubiaceae) subsumed on the basis of molecular and morphological data; implications for the size, morphology, distribution and evolutionary history of Coffea. Botanical Journal of the Linnean Society 167 357–377. (https://doi.org/10.1111/j.1095-8339.2011.01177.x)
Davoodi SH, Hajimiresmaiel SJ, Ajami M, Mohseni-Bandpei A, Ayatollahi SA, Dowlatshahi K, Javedan G & & Pazoki-Toroudi H 2014 Caffeine treatment prevented from weight regain after calorie shifting diet induced weight loss. Iranian Journal of Pharmaceutical Research 13 707–718.
Denaro CP, Brown CR, Wilson M, Jacob P 3rd & & Benowitz NL 1990 Dose-dependency of caffeine metabolism with repeated dosing. Clinical Pharmacology and Therapeutics 48 277–285. (https://doi.org/10.1038/clpt.1990.150)
Denoeud F, Carretero-Paulet L, Dereeper A, Droc G, Guyot R, Pietrella M, Zheng C, Alberti A, Anthony F, Aprea G, et al.2014 The coffee genome provides insight into the convergent evolution of caffeine biosynthesis. Science 345 1181–1184. (https://doi.org/10.1126/science.1255274)
Di Gioacchino M, Ricci MA & & Bruni F 2024 Science in a cup of coffee: a structural study of a trigonelline aqueous solution. Journal of Molecular Liquids 396 123972. (https://doi.org/10.1016/j.molliq.2024.123972)
Djordjevic N, Ghotbi R, Bertilsson L, Jankovic S & & Aklillu E 2008 Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. European Journal of Clinical Pharmacology 64 381–385. (https://doi.org/10.1007/s00228-007-0438-6)
Dos Santos ÉJ & & de Oliveira E 2001 Determination of mineral nutrients and toxic elements in Brazilian soluble coffee by ICP-AES. Journal of Food Composition and Analysis 14 523–531. (https://doi.org/10.1006/jfca.2001.1012)
Drouillard DD, Vesell ES & & Dvorchik BH 1978 Studies on theobromine disposition in normal subjects. Alterations induced by dietary abstention from or exposure to methylxanthines. Clinical Pharmacology and Therapeutics 23 296–302. (https://doi.org/10.1002/cpt1978233296)
Dulloo AG, Geissler CA, Horton T, Collins A & & Miller DS 1989 Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. American Journal of Clinical Nutrition 49 44–50. (https://doi.org/10.1093/ajcn/49.1.44)
Erblang M, Drogou C, Gomez-Merino D, Metlaine A, Boland A, Deleuze JF, Thomas C, Sauvet F & & Chennaoui M 2019 The impact of genetic variations in ADORA2A in the association between caffeine consumption and sleep. Genes 10. (https://doi.org/10.3390/genes10121021)
Essayan DM 2001 Cyclic nucleotide phosphodiesterases. Journal of Allergy and Clinical Immunology 108 671–680. (https://doi.org/10.1067/mai.2001.119555)
Farah A 2012 Coffee constituents. In Coffee: emerging health effects and disease prevention, ch 2, pp. 22–58. (https://doi.org/10.1002/9781119949893.ch2)
Ferré S, Guix T, Sallés J, Badia A, Parra P, Jané F, Herrera-Marschitz M, Ungerstedt U & & Casas M 1990 Paraxanthine displaces the binding of [3H] SCH 23390 from rat striatal membranes. European Journal of Pharmacology 179 295–299. (https://doi.org/10.1016/0014-2999(9090168-6)
Fisone G, Borgkvist A & & Usiello A 2004 Caffeine as a psychomotor stimulant: mechanism of action. Cellular and Molecular Life Sciences 61 857–872. (https://doi.org/10.1007/s00018-003-3269-3)
Foskett A, Ali A & & Gant N 2009 Caffeine enhances cognitive function and skill performance during simulated soccer activity. International Journal of Sport Nutrition and Exercise Metabolism 19 410–423. (https://doi.org/10.1123/ijsnem.19.4.410)
Francis SH, Blount MA & & Corbin JD 2011 Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. Physiological Reviews 91 651–690. (https://doi.org/10.1152/physrev.00030.2010)
Fredholm BB 1984 Cardiovascular and renal actions of methylxanthines. Progress in Clinical and Biological Research 158 303–330.
Fredholm BB, Bättig K, Holmén J, Nehlig A & & Zvartau EE 1999 Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews 51 83–133.
Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G & & Wasserman W 2000 Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg’s Archives of Pharmacology 362 364–374. (https://doi.org/10.1007/s002100000313)
Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN & & Linden J 2001 International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacological Reviews 53 527–552.
Fuxe K, Ferré S, Canals M, Torvinen M, Terasmaa A, Marcellino D, Goldberg SR, Staines W, Jacobsen KX, Lluis C, et al.2005 Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. Journal of Molecular Neuroscience 26 209–220. (https://doi.org/10.1385/JMN:26:2-3:209)
Fuxe K, Ferré S, Genedani S, Franco R & & Agnati LF 2007 Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiology and Behavior 92 210–217. (https://doi.org/10.1016/j.physbeh.2007.05.034)
Gans JH, Korson R, Cater MR & & Ackerly CC 1980 Effects of short-term and long-term theobromine administration to male dogs. Toxicology and Applied Pharmacology 53 481–496. (https://doi.org/10.1016/0041-008x(8090360-9)
Garrett R, Rezende CM & & Ifa DR 2016 Revealing the spatial distribution of chlorogenic acids and sucrose across coffee bean endosperm by desorption electrospray ionization-mass spectrometry imaging. LWT – Food Science and Technology 65 711–717. (https://doi.org/10.1016/j.lwt.2015.08.062)
Garthwaite J 2008 Concepts of neural nitric oxide-mediated transmission. European Journal of Neuroscience 27 2783–2802. (https://doi.org/10.1111/j.1460-9568.2008.06285.x)
Gates S & & Miners JO 1999 Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. British Journal of Clinical Pharmacology 47 299–305. (https://doi.org/10.1046/j.1365-2125.1999.00890.x)
Ge Y, Wang B, Shi X, Zhang Z, Qi M, Du H, Qu P, Jiang K, Chen Z & & Li X 2024 Multi-omics analyses unravel genetic relationship of Chinese coffee germplasm resources. Forests 15 163. (https://doi.org/10.3390/f15010163)
Gebreselassie H, Tesfaye B & & Gedebo A 2024 Genetic diversity of arabica coffee genotypes in south Ethiopia using quantitative agro-morphological traits. Genetic Resources and Crop Evolution 1–22. (https://doi.org/10.1007/s10722-023-01853-9)
George J, Murphy T, Roberts R, Cooksley WG, Halliday JW & & Powell LW 1986 Influence of alcohol and caffeine consumption on caffeine elimination. Clinical and Experimental Pharmacology and Physiology 13 731–736. (https://doi.org/10.1111/j.1440-1681.1986.tb02414.x)
Geromel C, Ferreira LP, Guerreiro SM, Cavalari AA, Pot D, Pereira LF, Leroy T, Vieira LG, Mazzafera P & & Marraccini P 2006 Biochemical and genomic analysis of sucrose metabolism during coffee (Coffea arabica) fruit development. Journal of Experimental Botany 57 3243–3258. (https://doi.org/10.1093/jxb/erl084)
Gloess AN, Yeretzian C, Knochenmuss R & & Groessl M 2018 On-line analysis of coffee roasting with ion mobility spectrometry–mass spectrometry (IMS–MS). International Journal of Mass Spectrometry 424 49–57. (https://doi.org/10.1016/j.ijms.2017.11.017)
Gniechwitz D, Reichardt N, Meiss E, Ralph J, Steinhart H, Blaut M & & Bunzel M 2008 Characterization and fermentability of an ethanol soluble high molecular weight coffee fraction. Journal of Agricultural and Food Chemistry 56 5960–5969. (https://doi.org/10.1021/jf800231q)
Gonzales-Yépez KA, Vilela JL & & Reátegui O 2023 Determination of caffeine, theobromine, and theophylline by HPLC-DAD in beverages commonly consumed in Lima, Peru. International Journal of Food Science 2023 4323645. (https://doi.org/10.1155/2023/4323645)
Gottstein V, Krumbügel K, Kuballa T, Schwarz S, Walch E, Walch P & & Lachenmeier DW 2023 Monitoring of chemical changes in coffee beans during the roasting process using different roasting technologies with nuclear magnetic resonance spectroscopy. Beverages 9 87. (https://doi.org/10.3390/beverages9040087)
Grant DM, Tang BK & & Kalow W 1983 Variability in caffeine metabolism. Clinical Pharmacology and Therapeutics 33 591–602. (https://doi.org/10.1038/clpt.1983.80)
Grembecka M, Malinowska E & & Szefer P 2007 Differentiation of market coffee and its infusions in view of their mineral composition. Science of the Total Environment 383 59–69. (https://doi.org/10.1016/j.scitotenv.2007.04.031)
Gu L, Gonzalez FJ, Kalow W & & Tang BK 1992 Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2 73–77. (https://doi.org/10.1097/00008571-199204000-00004)
Guerrero G, Suárez M & & Moreno G 2005 Chemosystematic study of diterpenoids in green coffee beans. 20th International Colloquium on the Chemistry of Coffee, vol 292. Paris, France: ASIC.
Guerreiro S, Toulorge D, Hirsch E, Marien M, Sokoloff P & & Michel PP 2008 Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Molecular Pharmacology 74 980–989. (https://doi.org/10.1124/mol.108.048207)
Guest N, Corey P, Vescovi J & & El-Sohemy A 2018 Caffeine, CYP1A2 genotype, and endurance performance in athletes. Medicine and Science in Sports and Exercise 50 1570–1578. (https://doi.org/10.1249/MSS.0000000000001596)
Hall RD, Trevisan F & & de Vos RCH 2022 Coffee berry and green bean chemistry - Opportunities for improving cup quality and crop circularity. Food Research International 151 110825. (https://doi.org/10.1016/j.foodres.2021.110825)
Harpaz E, Tamir S, Weinstein A & & Weinstein Y 2017 The effect of caffeine on energy balance. Journal of Basic and Clinical Physiology and Pharmacology 28 1–10. (https://doi.org/10.1515/jbcpp-2016-0090)
Haskó G & & Cronstein B 2011 Methylxanthines and inflammatory cells. Handbook of Experimental Pharmacology 200 457–468. (https://doi.org/10.1007/978-3-642-13443-2_18)
Herling AW, Burger H-J, Schubert G, Hemmerle H, Schaefer H-L & & Kramer W 1999 Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. European Journal of Pharmacology 386 75–82. (https://doi.org/10.1016/s0014-2999(9900748-7)
Hirakawa N, Okauchi R, Miura Y & & Yagasaki K 2005 Anti-invasive activity of niacin and trigonelline against cancer cells. Bioscience, Biotechnology, and Biochemistry 69 653–658. (https://doi.org/10.1271/bbb.69.653)
Hobhouse H 2005 Seeds of wealth: five plants that made men rich. New York, NY, USA: Catapult.
Hollands MA, Arch JR & & Cawthorne MA 1981 A simple apparatus for comparative measurements of energy expenditure in human subjects: the thermic effect of caffeine. American Journal of Clinical Nutrition 34 2291–2294. (https://doi.org/10.1093/ajcn/34.10.2291)
Hu GL, Wang X, Zhang L & & Qiu MH 2019 The sources and mechanisms of bioactive ingredients in coffee. Food and Function 10 3113–3126. (https://doi.org/10.1039/c9fo00288j)
IARC 1991 IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 27 February to 6 March 1990. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 51 1–513.
Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM & & Barnes PJ 2002 A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proceedings of the National Academy of Sciences of the United States of America 99 8921–8926. (https://doi.org/10.1073/pnas.132556899)
Jaiswal R, Patras MA, Eravuchira PJ & & Kuhnert N 2010 Profile and characterization of the chlorogenic acids in green robusta coffee beans by LC-MS(n): identification of seven new classes of compounds. Journal of Agricultural and Food Chemistry 58 8722–8737. (https://doi.org/10.1021/jf1014457)
Jenne JW, Wyze MS, Rood FS & & MacDonald FM 1972 Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clinical Pharmacology and Therapeutics 13 349–360. (https://doi.org/10.1002/cpt1972133349)
Johnston KL, Clifford MN & & Morgan LM 2003 Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. American Journal of Clinical Nutrition 78 728–733. (https://doi.org/10.1093/ajcn/78.4.728)
Jonasson O 1933 Natural conditions for coffee culture. Economic Geography 9 356–367. (https://doi.org/10.2307/140490)
Kadlec GJ, Jarboe CH, Pollard SJ & & Sublett JL 1978 Acute theophylline intoxication. Biphasic first order elimination kinetics in a child. Annals of Allergy 41 337–339.
Khemira H, Mahdhi M, Afzal M, Oteef MD, Tounekti T, Zarraq AF & & Alsolami W 2023 Assessment of genetic diversity and phylogenetic relationship of local coffee populations in southwestern Saudi Arabia using DNA barcoding. PeerJ 11 e16486. (https://doi.org/10.7717/peerj.16486)
Kitagawa M, Houzen H & & Tashiro K 2007 Effects of caffeine on the freezing of gait in Parkinson's disease. Movement Disorders 22 710–712. (https://doi.org/10.1002/mds.21208)
Kleinwächter M & & Selmar DJFC 2010 Influence of drying on the content of sugars in wet processed green Arabica coffees. Food Chemistry 119 500–504. (https://doi.org/10.1016/j.foodchem.2009.06.048)
Knutti R, Rothweiler H & & Schlatter C 1981 Effect of pregnancy on the pharmacokinetics of caffeine. European Journal of Clinical Pharmacology 21 121–126. (https://doi.org/10.1007/BF00637512)
Koot P & & Deurenberg P 1995 Comparison of changes in energy expenditure and body temperatures after caffeine consumption. Annals of Nutrition and Metabolism 39 135–142. (https://doi.org/10.1159/000177854)
Kotake AN, Schoeller DA, Lambert GH, Baker AL, Schaffer DD & & Josephs H 1982 The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers. Clinical Pharmacology and Therapeutics 32 261–269. (https://doi.org/10.1038/clpt.1982.157)
Kramer D, Breitenstein B, Kleinwächter M & & Selmar D 2010 Stress metabolism in green coffee beans (Coffea arabica L.): expression of dehydrins and accumulation of GABA during drying. Plant and Cell Physiology 51 546–553. (https://doi.org/10.1093/pcp/pcq019)
Lam LK, Sparnins VL & & Wattenberg LW 1987 Effects of derivatives of kahweol and cafestol on the activity of glutathione S-transferase in mice. Journal of Medicinal Chemistry 30 1399–1403. (https://doi.org/10.1021/jm00391a022)
Landi MT, Sinha R, Lang NP & & Kadlubar FF 1999 Human cytochrome P4501A2. IARC Scientific Publications 148 173–195.
Lang R, Wahl A, Stark T & & Hofmann T 2011 Urinary N-methylpyridinium and trigonelline as candidate dietary biomarkers of coffee consumption. Molecular Nutrition and Food Research 55 1613–1623. (https://doi.org/10.1002/mnfr.201000656)
Lee KJ, Choi JH & & Jeong HG 2007 Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food and Chemical Toxicology 45 2118–2125. (https://doi.org/10.1016/j.fct.2007.05.010)
Lima CS, Spindola DG, Bechara A, Garcia DM, Palmeira-Dos-Santos C, Peixoto-da-Silva J, Erustes AG, Michelin LFG, Pereira GJS, Smaili SS, et al.2017 Cafestol, a diterpene molecule found in coffee, induces leukemia cell death. Biomedicine and Pharmacotherapy 92 1045–1054. (https://doi.org/10.1016/j.biopha.2017.05.109)
Lopane SN, McGregor JU & & Rieck JR 2024 An investigation of the shelf life of cold brew coffee and the influence of extraction temperature using chemical, microbial, and sensory analysis. Food Science and Nutrition 12 985–996. (https://doi.org/10.1002/fsn3.3812)
López-Galilea I, Fournier N, Cid C & & Guichard E 2006 Changes in headspace volatile concentrations of coffee brews caused by the roasting process and the brewing procedure. Journal of Agricultural and Food Chemistry 54 8560–8566. (https://doi.org/10.1021/jf061178t)
Ludwig IA, Clifford MN, Lean ME, Ashihara H & & Crozier A 2014 Coffee: biochemistry and potential impact on health. Food and Function 5 1695–1717. (https://doi.org/10.1039/c4fo00042k)
Magkos F & & Kavouras SA 2005 Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action. Critical Reviews in Food Science and Nutrition 45 535–562. (https://doi.org/10.1080/1040-830491379245)
Mahdavi S, Palatini P & & El-Sohemy A 2023 CYP1A2 genetic variation, coffee intake, and kidney dysfunction. JAMA Network Open 6 e2247868. (https://doi.org/10.1001/jamanetworkopen.2022.47868)
McCusker RR, Goldberger BA & & Cone EJ 2003 Caffeine content of specialty coffees. Journal of Analytical Toxicology 27 520–522. (https://doi.org/10.1093/jat/27.7.520)
McPherson PS, Kim YK, Valdivia H, Knudson CM, Takekura H, Franzini-Armstrong C, Coronado R & & Campbell KP 1991 The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron 7 17–25. (https://doi.org/10.1016/0896-6273(9190070-g)
Miller CA, Slusher LB & & Vesell ES 1985 Polymorphism of theophylline metabolism in man. Journal of Clinical Investigation 75 1415–1425. (https://doi.org/10.1172/JCI111843)
Mitani T, Watanabe S, Yoshioka Y, Katayama S, Nakamura S & & Ashida H 2017 Theobromine suppresses adipogenesis through enhancement of CCAAT-enhancer-binding protein β degradation by adenosine receptor A1. Biochimica et Biophysica Acta. Molecular Cell Research 1864 2438–2448. (https://doi.org/10.1016/j.bbamcr.2017.09.017)
Monteiro MC & & Farah A 2012 Chlorogenic acids in Brazilian Coffea arabica cultivars from various consecutive crops. Food Chemistry 134 611–614. (https://doi.org/10.1016/j.foodchem.2012.02.118)
Moreira RFA, Trugo LC & & De Maria CAB 2000 Componentes voláteis do café torrado. Parte II. Compostos alifáticos, alicíclicos e aromáticos. Quimica Nova 23 195–203. (https://doi.org/10.1590/S0100-40422000000200010)
Mosier K, Renvall MJ, Ramsdell JW & & Spindler AA 1996 The effects of theophylline on metabolic rate in chronic obstructive lung disease patients. Journal of the American College of Nutrition 15 403–407. (https://doi.org/10.1080/07315724.1996.10718616)
Muriel P & & Arauz J 2010 Coffee and liver diseases. Fitoterapia 81 297–305. (https://doi.org/10.1016/j.fitote.2009.10.003)
Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M & & Kamataki T 1999 Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. Journal of Biochemistry 125 803–808. (https://doi.org/10.1093/oxfordjournals.jbchem.a022352)
Navarro G, Borroto-Escuela DO, Fuxe K & & Franco R 2016 Purinergic signaling in Parkinson's disease. Relevance for treatment. Neuropharmacology 104 161–168. (https://doi.org/10.1016/j.neuropharm.2015.07.024)
Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A & & Feeley M 2003 Effects of caffeine on human health. Food Additives and Contaminants 20 1–30. (https://doi.org/10.1080/0265203021000007840)
Nehlig A 2018 Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacological Reviews 70 384–411. (https://doi.org/10.1124/pr.117.014407)
Newton R, Broughton LJ, Lind MJ, Morrison PJ, Rogers HJ & & Bradbrook ID 1981 Plasma and salivary pharmacokinetics of caffeine in man. European Journal of Clinical Pharmacology 21 45–52. (https://doi.org/10.1007/BF00609587)
Nogrady B 2024 All arabica coffee is genetically similar: how can beans taste so different? Nature. (https://doi.org/10.1038/d41586-024-00165-x)
Noirot M, Charrier A, Stoffelen P & & Anthony F 2016 Reproductive isolation, gene flow and speciation in the former Coffea subgenus: a review. Trees 30 597–608. (https://doi.org/10.1007/s00468-015-1335-8)
Nomura S & & Monobe M 2023 Comparing effects of caffeine and theobromine on adrenal hypertrophy and social behavior in psychosocial stressed mice. Journal of Nutritional Science and Vitaminology 69 145–149. (https://doi.org/10.3177/jnsv.69.145)
Novaes FJM, Oigman SS, de Souza ROMA, Rezende CM & & de Aquino Neto FR 2015 New approaches on the analyses of thermolabile coffee diterpenes by gas chromatography and its relationship with cup quality. Talanta 139 159–166. (https://doi.org/10.1016/j.talanta.2014.12.025)
Novaes FJM, da Silva MAE, Silva DC, Aquino Neto FRD & & Rezende CM 2023 Extraction of diterpene-phytochemicals in raw and roasted coffee beans and beverage preparations and their relationship. Plants 12 1580.
Nunes RA, Mazzotti DR, Hirotsu C, Andersen ML, Tufik S & & Bittencourt L 2017 The association between caffeine consumption and objective sleep variables is dependent on ADORA2A c.1083T>C genotypes. Sleep Medicine 30 210–215. (https://doi.org/10.1016/j.sleep.2016.06.038)
Orrú M, Guitart X, Karcz-Kubicha M, Solinas M, Justinova Z, Barodia SK, Zanoveli J, Cortes A, Lluis C, Casado V, et al.2013 Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans. Neuropharmacology 67 476–484. (https://doi.org/10.1016/j.neuropharm.2012.11.029)
Patwardhan RV, Desmond PV, Johnson RF & & Schenker S 1980 Impaired elimination of caffeine by oral contraceptive steroids. Journal of Laboratory and Clinical Medicine 95 603–608.
Reichardt N, Gniechwitz D, Steinhart H, Bunzel M & & Blaut M 2009 Characterization of high molecular weight coffee fractions and their fermentation by human intestinal microbiota. Molecular Nutrition and Food Research 53 287–299. (https://doi.org/10.1002/mnfr.200700509)
Relling MV, Lin JS, Ayers GD & & Evans WE 1992 Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clinical Pharmacology and Therapeutics 52 643–658. (https://doi.org/10.1038/clpt.1992.203)
Ribeiro JA & & Sebastião AM 2010 Caffeine and adenosine. Journal of Alzheimer's Disease 20(Supplement 1) S3–S15. (https://doi.org/10.3233/JAD-2010-1379)
Roberts EA, Furuya KN, Tang BK & & Kalow W 1994 Caffeine biotransformation in human hepatocyte lines derived from normal liver tissue. Biochemical and Biophysical Research Communications 201 559–566. (https://doi.org/10.1006/bbrc.1994.1738)
Rocha PLA, Lima ALC, Saunders B & & Reis CEG 2022 Development of a caffeine content table for foods, drinks, medications and supplements typically consumed by the Brazilian population. Nutrients 14. (https://doi.org/10.3390/nu14204417)
Rudelle S, Ferruzzi MG, Cristiani I, Moulin J, Macé K, Acheson KJ & & Tappy L 2007 Effect of a thermogenic beverage on 24-hour energy metabolism in humans. Obesity (Silver Spring) 15 349–355. (https://doi.org/10.1038/oby.2007.529)
Rufián-Henares JA & & Morales FJ 2007 Effect of in vitro enzymatic digestion on antioxidant activity of coffee melanoidins and fractions. Journal of Agricultural and Food Chemistry 55 10016–10021. (https://doi.org/10.1021/jf0718291)
Rufián-Henares JA & & de la Cueva SP 2009 Antimicrobial activity of coffee melanoidins-a study of their metal-chelating properties. Journal of Agricultural and Food Chemistry 57 432–438. (https://doi.org/10.1021/jf8027842)
Rusinek R, Dobrzański B Jr, Gawrysiak-Witulska M, Siger A, Żytek A, Karami H, Umar A, Lipa T & & Gancarz M 2024 Effect of the roasting level on the content of bioactive and aromatic compounds in arabica coffee beans. International Agrophysics 38 31–42. (https://doi.org/10.31545/intagr/176300)
Sachse C, Brockmöller J, Bauer S & & Roots I 1999 Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. British Journal of Clinical Pharmacology 47 445–449. (https://doi.org/10.1046/j.1365-2125.1999.00898.x)
Sanchez JM 2017 Methylxanthine content in commonly consumed foods in Spain and determination of its intake during consumption. Foods 6. (https://doi.org/10.3390/foods6120109)
Sattin A & & Rall TW 1970 The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. Molecular Pharmacology 6 13–23.
Sawynok J & & Yaksh TL 1993 Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacological Reviews 45 43–85.
Shofinita D, Lestari D, Aliwarga L, Sumampouw GA, Ambarwati SA, Gunawan KC & & Achmadi AB 2024 Drying methods of coffee extracts and their effects on physicochemical properties: a review. Food and Bioprocess Technology 17 47–72. (https://doi.org/10.1007/s11947-023-03067-4)
Simon C, Herling AW, Preibisch G & & Burger HJ 2000 Upregulation of hepatic glucose 6-phosphatase gene expression in rats treated with an inhibitor of glucose-6-phosphate translocase. Archives of Biochemistry and Biophysics 373 418–428. (https://doi.org/10.1006/abbi.1999.1560)